-
公开(公告)号:PE03772005A1
公开(公告)日:2005-05-30
申请号:PE0008892004
申请日:2004-09-14
Applicant: SCHERING CORP , PHARMACOPEIA DRUG DISCOVERY
Inventor: SMITH ELIZABETH M , CLADER JOHN W , HOBBS DOUGLAS W , JOSIEN HUBERT B , ASBEROM THEODROS , GUO TAO , PISSARNITSKI DMITRI A
IPC: C07D491/113 , A61K31/44 , A61K31/445 , A61K31/4535 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61P25/18 , A61P25/28 , A61P43/00 , C07D207/48 , C07D211/96 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/10
CPC classification number: C07D401/14 , C07D207/08 , C07D211/96 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/14 , C07D451/06 , C07D471/04 , C07D471/10 , C07D491/10
Abstract: REFERIDA A UN COMPUESTO DE FORMULA I, O A UNA DE SUS SALES, SOLVATOS O ESTERES, DONDE R1 ES ARILO SUSTITUIDO O NO, HETEROARILO SUSTITUIDO O NO; R2 ES ALQUILO, ARILO, HETEROARILO, ENTRE OTROS; R3 ES H, ACILO, -OH, ENTRE OTROS; R3A Y R3B SON CADA UNO H O ALQUILO; R5 ES HALO, -CF3, -CN, ENTRE OTROS; R11 ES ALCOXIALQUILO, ALQUILO, CICLOALQUILO, ENTRE OTROS; m ES 0-3; n ES 0-3; o ES 0-3. TAMBIEN REFERIDA A UN METODO DE INHIBICION DE LA GAMMA-SECRETASA Y OTRO DE INHIBICION DE LA DEPOSICION DE LA PROTEINA BETA AMILOIDE PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER
-
公开(公告)号:ZA200400696B
公开(公告)日:2005-04-28
申请号:ZA200400696
申请日:2004-01-28
Applicant: SCHERING CORP
Inventor: ASBEROM THEODROS , JOSIEN HUBERT B , GUZIK HENRY S , PISSARNITSKI DMITRI A
IPC: C07D20060101 , C07D
-
公开(公告)号:AU2004274449A1
公开(公告)日:2005-03-31
申请号:AU2004274449
申请日:2004-09-15
Applicant: PHARMACOPEIA INC , SCHERING CORP
Inventor: SMITH ELIZABETH M , PISSARNITSKI DMITRI A , GUO TAO , CLADER JOHN W , HOBBS DOUGLAS W , JOSIEN HUBERT B , ASBEROM THEODROS
IPC: C07D211/96 , C07D491/113 , A61K31/44 , A61K31/445 , A61K31/4535 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61P25/18 , A61P25/28 , A61P43/00 , C07D207/48 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/10
Abstract: This invention discloses novel gamma secretase inhibitors of the formula: wherein: R is a substituted aryl or substituted heteroaryl group; R is an R group, alkyl, -XC(O)Y, alkylene-XC(O)Y, cycloalkylene-X-C(O)-Y, -CH-X-C(O)-NR -Y or -CH-X-C(O)-Y, wherein X and Y are as defined herein; each R and each R are independently H, or alkyl; R is aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, or alkoxyalkyl. Also disclosed is a method of treating Alzheimer's Disease using one or more compounds of the invention.
-
公开(公告)号:NO20040933L
公开(公告)日:2004-03-03
申请号:NO20040933
申请日:2004-03-03
Applicant: SCHERING CORP
Inventor: ASBEROM THEODROS , JOSIEN HUBERT B , GUZIK HENRY S , PISSAMITSKI DMITRI A
IPC: A61K31/437 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61P9/10 , A61P25/00 , A61P25/28 , A61P43/00 , C07D215/58 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D521/00 , C07D
Abstract: This invention discloses novel gamma secretase inhibitors of the formula: wherein: R1 is a substituted aryl or substituted heteroaryl group; R2 is an R1 group, alkyl, -X(CO)Y, -(CR32)1-4X(CO)Y; each R3A is independently H or alkyl; X is -O-, -NH, or -N-alkyl; and Y is -NR6R7, or -N(R3)(CH2)2-6NR6R7. Also disclosed is a method of treating Alzheimer's Disease.
-
公开(公告)号:DE69631370D1
公开(公告)日:2004-02-26
申请号:DE69631370
申请日:1996-02-16
Applicant: SCHERING CORP
Inventor: LOWE DEREK , CHANG WEI , KOZLOWSKI JOSEPH , BERGER G , MCQUADE ROBERT , BARNETT ALLEN , SCHERLOCK MARGARET , TOM WING , DUGAR SUNDEEP , CHEN LIAN-YONG , CLADER W , CHACKALAMANNIL SAMUEL , MCCOMBIE STUART W , TAGAT JAYARAM R , VICE SUSAN F , VACCARO WAYNE , WANG YUGUANG , GREEN MICHAEL J , BROWNE MARGARET E , ASBEROM THEODROS
IPC: C07D295/08 , A61K31/335 , A61K31/357 , A61K31/36 , A61K31/365 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4468 , A61K31/451 , A61K31/495 , A61K31/496 , A61K31/505 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61P25/28 , C07D211/14 , C07D211/22 , C07D211/24 , C07D211/26 , C07D211/32 , C07D211/58 , C07D211/62 , C07D239/34 , C07D257/04 , C07D271/06 , C07D295/02 , C07D295/03 , C07D295/084 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/12 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/14 , C07D295/145 , C07D295/15 , C07D307/33 , C07D309/12 , C07D317/28 , C07D317/62 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D401/10 , C07D403/10 , C07D407/04 , C07D413/10
Abstract: Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) wherein R, R1, R2, R3, R4, R21, R27, R28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula or other compounds capable of enhancing acetylcholine release with acetylcholinesterase inhibitors.
-
公开(公告)号:DE69719354T2
公开(公告)日:2003-12-04
申请号:DE69719354
申请日:1997-08-06
Applicant: SCHERING CORP
Inventor: LOWE B , CHANG K , KOZLOWSKI A , BERGER G , MCQUADE ROBERT , BARNETT ALLEN , SHERLOCK MARGARET , TOM WING , DUGAR SUNDEEP , CHEN LIAN-YONG , CLADER W , CHACKALAMANNIL SAMUEL , WANG YUGUANG , MCCOMBIE W , TAGAT R , VICE F , VACCARO D , GREEN J , BROWNE E , BOYLE D , JOSIEN B , ASBEROM THEODROS
IPC: C07D211/58 , A61K31/00 , A61K31/435 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4523 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/50 , A61K31/501 , A61K45/00 , A61P25/28 , C07D211/24 , C07D211/32 , C07D211/96 , C07D239/34 , C07D257/04 , C07D295/02 , C07D295/03 , C07D295/084 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/145 , C07D295/15 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/14 , C07D405/00
Abstract: Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) wherein R, R1, R2, R3, R4, R21, R27, R28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula with acetylcholinesterase inhibitors.
-
公开(公告)号:PE20030415A1
公开(公告)日:2003-05-22
申请号:PE2002000821
申请日:2002-08-27
Applicant: SCHERING CORP
Inventor: ASBEROM THEODROS , CHACKALAMANNIL SAMUEL , CLADER JOHN W , XU RUO , PISSARNITSKI DMITRI , STAMFORD ANDREW WILLIAM , WANG YUGUANG , HU YUEQING
IPC: A61K31/519 , A61K45/00 , A61P1/04 , A61P1/14 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P13/02 , A61P13/12 , A61P15/00 , A61P15/10 , A61P25/00 , A61P25/28 , A61P27/06 , A61P35/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P43/00 , C07D487/14 , C07D487/20
Abstract: SE REFIERE A COMPUESTOS DE FORMULAS I-1 Y II.1 DONDE q ES 0-1; R1 ES H, CICLOALQUILO, ALQUILO, R23-ALQUILO, R26; Ra, Rb, Rc SON H, ALQUILO, CICLOALQUILO, ARILO; Ra Y Rb FORMAN UN ANILLO DE 4 A 7 MIEMBROS, Rc ES H, ALQUILO; Ra Y Rb FORMAN UN ANILLO DE 4 A 7 MIEMBROS, Rb ES H, ALQUILO; i)X ES UN ENLACE; Y ES H, R26, CICLOALQUILO, ALQUILO, R25-ALQUILO, (CH2)tTCOR100, t ES 1-6; T ES O, NH; R100 ES H, R26-ALQUILO; R2 ES MONOHALOALQUILO, AZIDO, CIANO, OXIMINO, CICLOALQUENILO, HETEROARILO, R22-HETEROARILO, R27-ALQUILO; ii)X ES UNLACE; Y ES Q-V, Q ES UN ENLACE, ALQUILO C1-C8; V ES ARILO, R22-HETEROARILO, HETEROARILO; R2 ES H, HALO, CONHR6, CONR6R7, AZIDO, CIANO, C=N-OR6, CICLOALQUILO, ENTRE OTROS; iii)X ES O, S; R2 ES R26, CICLOALQUILO, CICLOALQUILALQUILO, HETEROCICLOALQUILO, ENTRE OTROS; iv)X ES O, S, R2 ES ALQUILO R26, CICLOALQUILO, CICLOALQUILALQUILO, ENTRE OTROS; SON COMPUESTOS PREFERIDOS 3-[(3-BROMO-4-HIDROXIFENIL)METIL]-5-ETIL-7,8-DIHIDRO-2-[(TETRAHIDRO-2H-PIRAN-4-IL)AMINO]-3H-IMIDAZO[2,1-b]PURIN-4-(5H)-ONA, 5'-ETIL-1'-[84-HIDROXIFENIL)METIL]-2'-(FENILETINIL)-ESPIRO[CICLOPENTANO-1,7'(8'H)-[1H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONA; ENTRE OTROS; TAMBIEN SE REFIERE AL USO DEL COMPUESTO CON UN PROSTANOIDE, AGONISTA DEL RECEPTOR DE DOPAMINA, AGONISTA DE RECEPTOR MELANOCORTINA. LOS COMPUESTOS ELEVAN LOS NIVELES DE cGMP Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE ENFERMEDAD UROGENITAL, VASCULAR PERIFERICA, ANGINA DE PECHO, RESTENOSIS DE POST ANGIOPLASTIA, DISFUNCION SEXUAL, IMPOTENCIA
-
公开(公告)号:CA2259655C
公开(公告)日:2003-05-13
申请号:CA2259655
申请日:1997-07-08
Applicant: SCHERING CORP
Inventor: GREEN MICHAEL J , ASBEROM THEODROS , LOWE DEREK B
IPC: A61K31/00 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/4545 , A61K45/06 , A61P25/28 , C07D211/58 , C07D405/12 , C07D405/14 , C07D409/14 , C07F7/10 , C07D401/12 , A61K31/47 , A61K31/495 , A61K31/535 , A61K31/695
Abstract: 1,4-Di-substituted piperidine muscarinic antagonists of formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, wherein X is a bond, -O-, -S-, -SO-, -SO2-, -CO-, -C(OR7)2-, -CH2-O-, -O-CH2-, -CH=CH-, -CH 2- , -CH(C1-C6 alkyl)-, -C(C1-C6 alkyl)2-, -CONR17-, -NR17CO-, -SO2NR17- or - NR17SO2-; R is C3-C6 cycloalkyl, (a), (b), (c), (d), (e), optionally substituted phenyl or optionally substituted pyridyl; R1 is H, -CN, -CF3, alkyl, cycloalkyl, cycloalkenyl, alkenyl, -COR15, -COO(alkyl, aryl, heteroaryl, alkylaryl or alkylheteroaryl), alkylaryl, alkylheteroaryl or - CON(R13)2; R2 is cycloalkyl, cycloalkenyl, t-butoxycarbonyl or optionally substituted 4-piperidinyl; R3 and R4 are H, halo, -CF3, alkyl, alkoxy or -OH ; R5 and R6 are H, alkyl, -CF3, alkoxy, -OH, alkylcarbonyl, alkoxycarbonyl, R13CONH-, R14OCONH-, R13NHCONH- or NH2CONR13-; R7 is H or alkyl, or the two R7 groups may form -(CH2)2-4; R13 is H, alkyl, cycloalkyl, -(alkyl)COOR15, aryl , heteroaryl, alkylaryl, alkylheteroaryl and adamantyl; R14 is H or alkyl; R15 is H, C1-C20 alkyl, C1-C6 cycloalkyl, aryl or heteroaryl; and R17 is H, C1-C 6 alkyl, aryl or heteroaryl; useful for treating cognitive disorders such as Alzheimer's disease are disclosed, as well as pharmaceutical compositions an d methods of preparation. Also disclosed are combinations of compounds of formula (I) capable of enhancing ACh release with ACh'ase inhibitors.
-
公开(公告)号:PT912515E
公开(公告)日:2003-03-31
申请号:PT97932321
申请日:1997-07-08
Applicant: SCHERING CORP
Inventor: ASBEROM THEODROS , LOWE DEREK B , GREEN MICHAEL J
IPC: A61K31/00 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/4545 , A61K45/06 , A61P25/28 , C07D211/58 , C07D405/12 , C07D405/14 , C07D409/14
Abstract: 1,4-Di-substituted piperidine muscarinic antagonists of formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, wherein X is a bond, -O-, -S-, -SO-, -SO2-, -CO-, -C(OR )2-, -CH2-O-, -O-CH2-, -CH=CH-, -CH2-, -CH(C1-C6 alkyl)-, -C(C1-C6 alkyl)2-, -CONR -, -NR CO-, -SO2NR - or -NR SO2-; R is C3-C6 cycloalkyl, (a), (b), (c), (d), (e), optionally substituted phenyl or optionally substituted pyridyl; R is H, -CN, -CF3, alkyl, cycloalkyl, cycloalkenyl, alkenyl, -COR , -COO(alkyl, aryl, heteroaryl, alkylaryl or alkylheteroaryl), alkylaryl, alkylheteroaryl or -CON(R )2; R is cycloalkyl, cycloalkenyl, t-butoxycarbonyl or optionally substituted 4-piperidinyl; R and R are H, halo, -CF3, alkyl, alkoxy or -OH; R and R are H, alkyl, -CF3, alkoxy, -OH, alkylcarbonyl, alkoxycarbonyl, R CONH-, R OCONH-, R NHCONH- or NH2CONR -; R is H or alkyl, or the two R groups may form -(CH2)2-4; R is H, alkyl, cycloalkyl, -(alkyl)COOR , aryl, heteroaryl, alkylaryl, alkylheteroaryl and adamantyl; R is H or alkyl; R is H, C1-C20 alkyl, C1-C6 cycloalkyl, aryl or heteroaryl; and R is H, C1-C6 alkyl, aryl or heteroaryl; useful for treating cognitive disorders such as Alzheimer's disease are disclosed, as well as pharmaceutical compositions and methods of preparation. Also disclosed are combinations of compounds of formula (I) capable of enhancing ACh release with ACh'ase inhibitors.
-
公开(公告)号:DK0912515T3
公开(公告)日:2003-03-10
申请号:DK97932321
申请日:1997-07-08
Applicant: SCHERING CORP
Inventor: ASBEROM THEODROS , LOWE DEREK B , GREEN MICHAEL J
IPC: A61K31/00 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/4545 , A61K45/06 , A61P25/28 , C07D211/58 , C07D405/12 , C07D405/14 , C07D409/14
Abstract: 1,4-Di-substituted piperidine muscarinic antagonists of formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, wherein X is a bond, -O-, -S-, -SO-, -SO2-, -CO-, -C(OR )2-, -CH2-O-, -O-CH2-, -CH=CH-, -CH2-, -CH(C1-C6 alkyl)-, -C(C1-C6 alkyl)2-, -CONR -, -NR CO-, -SO2NR - or -NR SO2-; R is C3-C6 cycloalkyl, (a), (b), (c), (d), (e), optionally substituted phenyl or optionally substituted pyridyl; R is H, -CN, -CF3, alkyl, cycloalkyl, cycloalkenyl, alkenyl, -COR , -COO(alkyl, aryl, heteroaryl, alkylaryl or alkylheteroaryl), alkylaryl, alkylheteroaryl or -CON(R )2; R is cycloalkyl, cycloalkenyl, t-butoxycarbonyl or optionally substituted 4-piperidinyl; R and R are H, halo, -CF3, alkyl, alkoxy or -OH; R and R are H, alkyl, -CF3, alkoxy, -OH, alkylcarbonyl, alkoxycarbonyl, R CONH-, R OCONH-, R NHCONH- or NH2CONR -; R is H or alkyl, or the two R groups may form -(CH2)2-4; R is H, alkyl, cycloalkyl, -(alkyl)COOR , aryl, heteroaryl, alkylaryl, alkylheteroaryl and adamantyl; R is H or alkyl; R is H, C1-C20 alkyl, C1-C6 cycloalkyl, aryl or heteroaryl; and R is H, C1-C6 alkyl, aryl or heteroaryl; useful for treating cognitive disorders such as Alzheimer's disease are disclosed, as well as pharmaceutical compositions and methods of preparation. Also disclosed are combinations of compounds of formula (I) capable of enhancing ACh release with ACh'ase inhibitors.
-
-
-
-
-
-
-
-
-